Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (71-80 of 387) with videos related to

Pageof 39
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|January 9, 2007
The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individualsEmma Guttman-Yassky, Reuven Bergman, Carcom Maor, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 31, 2024
Beyond Avoidance: Advanced Therapies for Contact DermatitisLu Yin, Benjamin Ungar, Emma Guttman-Yassky, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2025
Artificial intelligence in atopic dermatitis: A narrative reviewDaniel Liu, Benjamin D Hu, Jacob Glickman, et al.
International Journal of Molecular Sciences|October 16, 2025
Integrated Meta-Analysis of Scalp Transcriptomics and Serum Proteomics Defines Alopecia Areata Subtypes and Core Disease PathwaysLi Xi, Elena Peeva, Yuji Yamaguchi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2022
Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center StudyAngel D Pagan, Eden David, Benjamin Ungar, et al.
Journal of the American Academy of Dermatology|August 22, 2020
Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysisAnne-Sofie Halling, Nikolai Loft, Jonathan I Silverberg, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 9, 2021
Biologics for Treatment of Atopic Dermatitis: Current Status and Future ProspectThanaporn Ratchataswan, Tina M Banzon, Jacob P Thyssen, et al.
Dermatology and Therapy|September 6, 2025
Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic DermatitisEmma Guttman-Yassky, Eric Simpson, Ehsanollah Esfandiari, et al.
Expert Opinion on Therapeutic Targets|June 25, 2026
The biological role of CCR4 and its ligands CCL17 and CCL22 in atopic dermatitis: therapeutic implications and future directionsDante Dahabreh, Dev Patel, Ester Del Duca, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2023
Comorbidities of atopic dermatitis-what does the evidence say?Jacob P Thyssen, Anne-Sofie Halling, Peter Schmid-Grendelmeier, et al.
Pageof 39

Showing results (71-80 of 387) with videos related to

Sort By:
Pageof 39
Journal of the European Academy of Dermatology and Venereology : JEADV|January 9, 2007
The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individualsEmma Guttman-Yassky, Reuven Bergman, Carcom Maor, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 31, 2024
Beyond Avoidance: Advanced Therapies for Contact DermatitisLu Yin, Benjamin Ungar, Emma Guttman-Yassky, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2025
Artificial intelligence in atopic dermatitis: A narrative reviewDaniel Liu, Benjamin D Hu, Jacob Glickman, et al.
International Journal of Molecular Sciences|October 16, 2025
Integrated Meta-Analysis of Scalp Transcriptomics and Serum Proteomics Defines Alopecia Areata Subtypes and Core Disease PathwaysLi Xi, Elena Peeva, Yuji Yamaguchi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2022
Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center StudyAngel D Pagan, Eden David, Benjamin Ungar, et al.
Journal of the American Academy of Dermatology|August 22, 2020
Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysisAnne-Sofie Halling, Nikolai Loft, Jonathan I Silverberg, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 9, 2021
Biologics for Treatment of Atopic Dermatitis: Current Status and Future ProspectThanaporn Ratchataswan, Tina M Banzon, Jacob P Thyssen, et al.
Dermatology and Therapy|September 6, 2025
Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic DermatitisEmma Guttman-Yassky, Eric Simpson, Ehsanollah Esfandiari, et al.
Expert Opinion on Therapeutic Targets|June 25, 2026
The biological role of CCR4 and its ligands CCL17 and CCL22 in atopic dermatitis: therapeutic implications and future directionsDante Dahabreh, Dev Patel, Ester Del Duca, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2023
Comorbidities of atopic dermatitis-what does the evidence say?Jacob P Thyssen, Anne-Sofie Halling, Peter Schmid-Grendelmeier, et al.
Pageof 39